Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
作者信息
Heffler Enrico, Detoraki Aikaterini, Contoli Marco, Papi Alberto, Paoletti Giovanni, Malipiero Giacomo, Brussino Luisa, Crimi Claudia, Morrone Daniela, Padovani Marianna, Guida Giuseppe, Gerli Alberto Giovanni, Centanni Stefano, Senna Gianenrico, Paggiaro Pierluigi, Blasi Francesco, Canonica Giorgio Walter
机构信息
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
出版信息
Allergy. 2021 Mar;76(3):961-962. doi: 10.1111/all.14593.
Abstract
摘要
相似文献
1
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?回复：Kow CS等人。重症哮喘患者发生COVID-19严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):961-962. doi: 10.1111/all.14593.
2
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?重度哮喘患者发生 COVID-19 严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):959-960. doi: 10.1111/all.14589. Epub 2020 Oct 2.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
Reply to "Does asthma affect outcomes of patients with COVID-19 infections?".对《哮喘是否影响新型冠状病毒肺炎感染患者的预后？》的回复
J Allergy Clin Immunol Pract. 2021 Jan;9(1):594-595. doi: 10.1016/j.jaip.2020.09.020. Epub 2020 Sep 28.
5
[COVID-19 and asthma control].[新型冠状病毒肺炎与哮喘控制]
Rev Mal Respir. 2021 Jan;38(1):111-113. doi: 10.1016/j.rmr.2020.11.006. Epub 2020 Nov 17.
6
Does asthma affect outcomes of patients with COVID-19 infections?
J Allergy Clin Immunol Pract. 2021 Jan;9(1):594. doi: 10.1016/j.jaip.2020.09.019. Epub 2020 Sep 28.
7
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.为何 COVID-19 患者的哮喘发病率较低，这证明了将 EDTA 溶液重新用于预防和治疗 COVID-19 疾病是合理的。
Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26.
8
[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]
Rev Med Liege. 2020;75(S1):130-132.
9
Asthmatic patients and COVID-19: Different disease course?哮喘患者与2019冠状病毒病：病程不同？
Allergy. 2021 Mar;76(3):963-965. doi: 10.1111/all.14601.
10
The evidence is in that asthma is not associated with severe coronavirus disease 2019.有证据表明，哮喘与严重的2019冠状病毒病无关。
Ann Allergy Asthma Immunol. 2021 May;126(5):451-452. doi: 10.1016/j.anai.2021.02.023.
引用本文的文献
1
Recent advances and developments in COVID-19 in the context of allergic diseases.新冠病毒肺炎在过敏性疾病背景下的最新进展与动态
Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065.
2
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia.对既往 SARS-CoV-2 肺炎患者在 3 个月和 6 个月时的肺功能进行前瞻性评估。
Respir Med. 2021 Sep;186:106541. doi: 10.1016/j.rmed.2021.106541. Epub 2021 Jul 10.
本文引用的文献
1
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?重度哮喘患者发生 COVID-19 严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):959-960. doi: 10.1111/all.14589. Epub 2020 Oct 2.
2
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.过敏疾病与 COVID-19 的易感性和严重程度：一项全国性队列研究。
J Allergy Clin Immunol. 2020 Oct;146(4):790-798. doi: 10.1016/j.jaci.2020.08.008. Epub 2020 Aug 15.
3
Asthma among hospitalized patients with COVID-19 and related outcomes.COVID-19 住院患者中的哮喘及相关结局。
J Allergy Clin Immunol. 2020 Nov;146(5):1027-1034.e4. doi: 10.1016/j.jaci.2020.07.026. Epub 2020 Aug 6.
4
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.因严重急性呼吸综合征冠状病毒2型肺炎住院的哮喘患者的临床病程及结局：一项单中心回顾性研究。
Ann Allergy Asthma Immunol. 2020 Dec;125(6):707-709. doi: 10.1016/j.anai.2020.07.029. Epub 2020 Aug 1.
5
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.意大利重症哮喘网络（SANI）患者中的新型冠状病毒肺炎：临床特征、合并症的影响及治疗情况
Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020 Aug 20.
6
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.哮喘合并新型冠状病毒肺炎患者住院、重症监护及死亡的危险因素。
J Allergy Clin Immunol. 2020 Oct;146(4):808-812. doi: 10.1016/j.jaci.2020.07.018. Epub 2020 Jul 29.
7
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
8
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.初级保健中未选择的患者中哮喘和 COPD 的误诊和肺功能检查的使用不足。
Respir Med. 2018 Sep;142:48-52. doi: 10.1016/j.rmed.2018.07.015. Epub 2018 Jul 24.
Zotero 插件